JOINT FILING AGREEMENTJoint Filing Agreement • April 27th, 2018 • Boyalife Asset Holding II, Inc. • Laboratory apparatus & furniture
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, the undersigned hereby (i) agree to the joint filing with all other Reporting Persons (as such term is defined in the statement on Schedule 13D described below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the common stock, par value $.001 per share, of Cesca Therapeutics Inc. and (ii) agree that this Agreement be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.
STOCK PURCHASE AGREEMENTStock Purchase Agreement • August 5th, 2022 • Boyalife Asset Holding II, Inc. • Laboratory apparatus & furniture • Illinois
THIS STOCK PURCHASE AGREEMENT (this “Agreement”) is made as of July 28, 2022 by and between Boyalife Group Inc. (“Boyalife Group” or the “Purchaser”), and Boyalife Asset Holding II Inc (“BAHII” or the “Seller”) related to Common Stock and the Line-of-Credit of ThermoGenesis Holdings, Inc. (“ThermoGenesis”, or the “Company”) owned by the Seller.
